Product details Supply Impact Dates Further Details
CARLEVENT levodopa/carbidopa/entacapone 125/31.25/200 mg

AUST R: 195748

Active Ingredients: entacapone~levodopa~carbidopa monohydrate

Dosage From: Tablet, film coated
From: 31 Mar 2025

To: 26 Dec 2025
Shortage Status: Current

Availability: Unavailable

Reason: Manufacturing
SINEMET 100/25 levodopa/carbidopa 100 mg/25 mg

AUST R: 319330

Active Ingredients: levodopa~carbidopa monohydrate

Dosage From: Tablet, uncoated
From: 15 Sep 2025

To: 20 Nov 2025
Shortage Status: Resolved

Availability: Available

Reason: Manufacturing
CARLEVENT levodopa/carbidopa/entacapone 50/12.5/200 mg

AUST R: 195198

Active Ingredients: entacapone~levodopa~carbidopa monohydrate

Dosage From: Tablet, film coated
From: 11 Sep 2025

To: 26 Dec 2025
Shortage Status: Current

Availability: Limited Availability

Reason: Manufacturing
LECTEVA levodopa/carbidopa/entacapone 150 mg/37.5 mg

AUST R: 238864

Active Ingredients: levodopa~carbidopa monohydrate~entacapone

Dosage From: Tablet, film coated
From: 24 Sep 2025

To: 28 Feb 2026
Shortage Status: Current

Availability: Unavailable

Reason: Unexpected increase in consumer demand
LECTEVA levodopa/carbidopa/entacapone 200 mg/50 mg

AUST R: 238866

Active Ingredients: levodopa~carbidopa monohydrate~entacapone

Dosage From: Tablet, film coated
From: 24 Sep 2025

To: 28 Feb 2026
Shortage Status: Current

Availability: Limited Availability

Reason: Unexpected increase in consumer demand